Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients

Area of Science:

• Infectious Diseases
• Microbiology
• Public Health

Background:

• HIV infection is associated with increased risk of various infections.
• Vancomycin-resistant enterococci (VRE) are a significant cause of healthcare-associated infections.
• Understanding VRE colonization in nonhospitalized populations is crucial for infection control.

Purpose of the Study:

• To investigate the prevalence of fecal vancomycin-resistant enterococci (VRE) colonization.
• To assess potential risk factors for VRE colonization in HIV-infected individuals not residing in hospitals.
• To determine the association between prior antibacterial use and VRE colonization.

Main Methods:

• Prospective study of 89 nonhospitalized HIV-infected patients.
• Fecal samples were collected and analyzed for VRE.
• Patient demographics, including age, sex, race, and sexual orientation, were recorded.
• Detailed history of recent or ongoing antibacterial therapy was obtained.

Main Results:

• Vancomycin-resistant enterococci (VRE) were not isolated from any of the 89 patients studied.
• The study included a diverse group of patients: 70 men and 19 women, with various racial backgrounds.
• A majority of patients (60%) had a history of recent or ongoing antibacterial therapy.

Conclusions:

• Fecal VRE colonization appears to be absent in this cohort of nonhospitalized HIV-infected patients.
• The findings suggest that nonhospitalized HIV-infected individuals may not be a significant reservoir for VRE.
• Further research is warranted to confirm these findings in larger, diverse populations.